35° Sunny

Site search

Open user controls
- Log In Using Your Account
  Log In
  
  Don't have an account? Sign Up Today

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Home
- Contact Us
- Subscribe
News
Sports
Features
Classifieds
Obituaries
Subscribe
E-Edition
Community Choice

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

NeoGenomics, Inc. - Common Stock (NQ:NEO)

12.28 -0.04 (-0.28%)

Streaming Delayed Price Updated: 2:24 PM EST, Feb 3, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about NeoGenomics, Inc. - Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Where NeoGenomics Stands With Analysts ↗

November 05, 2021

Over the past 3 months, 4 analysts have published their opinion on NeoGenomics (NASDAQ:

Via Benzinga

81 Biggest Movers From Yesterday ↗

November 05, 2021

Gainers Evaxion Biotech A/S (NASDAQ: EVAX) shares jumped 95.1% to close at $12.68 on Thursday after dropping over 10% on Wednesday. TDH Holdings, Inc. (NASDAQ: PETZ) jumped 79.8...

Via Benzinga

Recap: NeoGenomics Q3 Earnings ↗

November 04, 2021

NeoGenomics (NASDAQ:NEO) reported its Q3 earnings results on Thursday, November 4, 2021 at 08:00 AM. Here's what investors need to know about the announcement. Earnings...

Via Benzinga

Recap: NeoGenomics Q2 Earnings ↗

August 06, 2021

Shares of NeoGenomics (NASDAQ:NEO) were unchanged after the company reported Q2 results. Quarterly Results Earnings per share were up 75.00% year over year to ($0.01),...

Via Benzinga

55 Stocks Moving In Thursday's Mid-Day Session ↗

November 04, 2021

Gainers Evaxion Biotech A/S (NASDAQ: EVAX) shares climbed 179% to $18.17 after dropping over 10% on Wednesday. NerdWallet, Inc. (NASDAQ: NRDS) jumped 60% to $28.86 after the...

Via Benzinga

NeoGenomics Reports Revenue of $121 Million in the Third Quarter

November 04, 2021

Third-Quarter 2021 Results and Highlights: - Consolidated revenue of $121 million, comprised of Clinical Services revenue of $102 million and Pharma Services revenue of $19 million - Consolidated...

From NeoGenomics, Inc.

Via AccessWire

Topics Regulatory Compliance Retirement

The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO ↗

November 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &...

Via Benzinga

NeoGenomics Announces Leadership Team Transition

November 04, 2021

FT. MYERS, FL / ACCESSWIRE / November 4, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, announced...

From NeoGenomics, Inc.

Via AccessWire

Topics Regulatory Compliance

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline ↗

October 31, 2021

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...

Via Benzinga

NeoGenomics' Liquid Biopsy Subsidiary Inivata Announces Clinical Collaboration With Princess Margaret Cancer Center for the Use of Its Liquid Biopsy Assays

October 19, 2021

Two clinical studies including interventional RaDaR™ study FT. MYERS, FL / ACCESSWIRE / October 19, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services...

From NeoGenomics, Inc.

Via AccessWire

Topics Regulatory Compliance

Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2021 ↗

October 14, 2021

Upgrades According to Roth Capital, the prior rating for Ring Energy Inc (AMEX:

Via Benzinga

NeoGenomics Schedules its Third Quarter 2021, Earnings Release for November 4, 2021

October 13, 2021

FT. MYERS, FL / ACCESSWIRE / October 13, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing and global contract research services, announced today that it plans...

From NeoGenomics, Inc.

Via AccessWire

Topics Regulatory Compliance

NeoGenomics Announces Board of Directors' Transition

October 12, 2021

Appoints Lead Independent Director Lynn Tetrault as Non-Executive Chair. Douglas VanOort steps-down as Executive Chairman and will retire from the Board of Directors before the end of the year FT....

From NeoGenomics, Inc.

Via AccessWire

Topics Regulatory Compliance Retirement

Guardant Health Will Not Go With NeoGenomics Deal: Bloomberg ↗

October 04, 2021

Guardant Health Inc (NASDAQ: GH) has decided not to pursue a potential acquisition of NeoGenomics Inc (NASDAQ: NEO), Bloomberg reported citing people...

Via Benzinga

Why Guardant Health Is Down More Than 14% Friday ↗

October 01, 2021

Investors aren't fans of an acquisition the diagnostics company is rumored to be considering.

Via The Motley Fool

Guardant Health Weighing NeoGenomics Acquisition: Bloomberg ↗

October 01, 2021

Bloomberg reported that Guardant Health Inc (NASDAQ: GH) is reportedly exploring an acquisition of NeoGenomics Inc (NASDAQ: NEO), citing people familiar...

Via Benzinga

NeoGenomics' Liquid Biopsy Subsidiary Inivata and Collaborators to Present Data that Further Validate the Application of its RaDaR(TM) MRD and InVisionFirst(R)-Lung Assays at the ESMO Congress 2021

September 09, 2021

FT MYERS, FL / ACCESSWIRE / September 9, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today...

From NeoGenomics, Inc.

Via AccessWire

Topics Regulatory Compliance

NeoGenomics to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference

September 01, 2021

FT. MYERS, FL / ACCESSWIRE / September 1, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today...

From NeoGenomics, Inc.

Via AccessWire

Topics Regulatory Compliance

Earnings Scheduled For August 12, 2021 ↗

August 12, 2021

Companies Reporting Before The Bell • Anavex Life Sciences (NASDAQ:AVXL) is estimated to report earnings for its third quarter. • ITeos Therapeutics (NASDAQ:ITOS...

Via Benzinga

NeoGenomics, inc (NEO) Q2 2021 Earnings Call Transcript ↗

August 06, 2021

NEO earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

NeoGenomics Q2 Earnings Helped By Higher Test Volume; Backs FY21 Guidance ↗

August 06, 2021

NeoGenomics Inc (NASDAQ: NEO) reported Q2 revenue of $122 million, +40% Y/Y, beating the consensus of $118.16 million. Clinical Services revenue of $101 million...

Via Benzinga

NeoGenomics Reports 40% Revenue Growth to $122 Million in the Second Quarter

August 06, 2021

Second-Quarter 2021 Results and Highlights: - Consolidated revenue increased 40% to $122 million - Clinical Services revenue increased 37% to $101 million - Pharma Services revenue increased 55% to $20...

From NeoGenomics, Inc.

Via AccessWire

Topics Regulatory Compliance Retirement

NeoGenomics Schedules its Second Quarter 2021 Earnings Release for August 6, 2021

July 14, 2021

FT. MYERS, FL / ACCESSWIRE / July 14, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing and global contract research services, announced today that it plans to...

From NeoGenomics, Inc.

Via AccessWire

Topics Regulatory Compliance

NeoGenomics Completes Inivata Acquisition - Combining Best-In-Class Liquid Biopsy Technology with Leading Community Oncology Platform

June 18, 2021

- Acquisition establishes NeoGenomics as a technology leader in the minimal residual disease (MRD) testing market FT. MYERS, FL / ACCESSWIRE / June 18, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading...

From NeoGenomics, Inc.

Via AccessWire

Topics Regulatory Compliance

Earnings Scheduled For August 6, 2021 ↗

August 06, 2021

Companies Reporting Before The Bell • Liberty Braves Group (NASDAQ:BATRA) is projected to report quarterly loss at $0.03 per share on revenue of $154.00 million....

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 3, 2021 ↗

June 03, 2021

Upgrades According to B of A Securities, the prior rating for Bloom Energy Corp (NYSE:BE) was changed from Underperform to Neutral. For the first quarter, Bloom Energy had...

Via Benzinga

NeoGenomics To Participate Virtually In Multiple Upcoming Institutional Investor Conferences

May 27, 2021

FT MYERS, FL / ACCESSWIRE / May 27, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced...

From NeoGenomics, Inc.

Via AccessWire

Topics Regulatory Compliance

These 7 Medical Stocks Are Breaking Down — The Sell Rule You Should Know ↗

May 13, 2021

Former high-flyers Dexcom and Tandem Diabetes are among seven health care stocks breaking down right now, according to MarketSmith.com.

Via Investor's Business Daily

NeoGenomics To Participate In The Bank of America 2021 Health Care Conference

May 10, 2021

FT. MYERS, FL / ACCESSSWIRE / May 10, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today...

From NeoGenomics, Inc.

Via AccessWire

Topics Regulatory Compliance

Earnings Scheduled For May 13, 2021 ↗

May 13, 2021

Companies Reporting Before The Bell • CASI Pharmaceuticals (NASDAQ:CASI) is estimated to report quarterly loss at $0.06 per share on revenue of $5.05 million. •...

Via Benzinga

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard Times

Services

Contact Us
Subscription Services
Promote Your Event
Site Forms
Search
California Privacy Notice

ricentral.com
187 Main Street
Wakefield, RI 02879
Phone: 401-789-9744
Email: news@ricentral.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Consent Preferences

Log In Using Your Account

NeoGenomics, Inc. - Common Stock (NQ:NEO)

All News about NeoGenomics, Inc. - Common Stock

Sections

Services